US5389549A — Method for classifying leukocytes and a reagent u…

Claim 1

Independent Claim 229 words

A reagent for classifying leukocytes in a blood sample that lyses erythrocytes and which acts on leukocytes to enable the classification and counting of leukocytes, said reagent comprising (a) a first fluid which is an agent for diluting blood and which contains a hyperosmotic agent to maintain the first fluid at an osmotic pressure of at least 285 mOsm; (b) a second fluid that contains a surfactant and which is to be added to a sample of blood that has been diluted with the first fluid said surfactant selected from the group consisting of: (i) a surfactant of a first group which is a polyoxyethylene-based anionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -X where R 1 is an alkyl, alkenyl, or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR10## or COO; n is an integer of 8-30 X is --SO 3 Na, COONa, OSO 3 Na or ONa; and (ii) a surfactant of a second group which is a polyoxyethylene-based nonionic surfactant represented by the formula: R 1 -R 1 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl, or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR11## or COO; n is an integer of 8-30; (c) a solubilizing agent that selectively reduces the size of monocytes in leukocytes.

Claim 2

Dependent Claim 229 words

A reagent for classifying leukocytes in a blood sample that lyses erythrocytes and which acts on leukocytes to enable the classification and counting of leukocytes, said reagent comprising (a) a first fluid which is an agent for diluting blood and which contains a hyperosmotic agent to maintain the first fluid at an osmotic pressure of at least 285 mOsm; (b) a second fluid that contains a surfactant and which is to be added to a sample of blood that has been diluted with the first fluid said surfactant selected from the group consisting of: (i) a surfactant of a first group which is a polyoxyethylene-based anionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -X where R 1 is an alkyl, alkenyl, or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR10## or COO; n is an integer of 8-30 X is --SO 3 Na, COONa, OSO 3 Na or ONa; and (ii) a surfactant of a second group which is a polyoxyethylene-based nonionic surfactant represented by the formula: R 1 -R 1 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl, or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR11## or COO; n is an integer of 8-30; (c) a solubilizing agent that selectively reduces the size of monocytes in leukocytes.

Claim 3

Dependent Claim 175 words

A reagent for classifying leukocytes in a blood sample that lyses erythrocytes and which acts on leukocytes to enable the classification and counting of leukocytes, said reagent consisting essentially of a solubilizing agent that selectively reduces the size of monocytes in leukocytes and at least one surfactant selected from the group consisting of: (a) a surfactant of a first group which is a polyoxyethylene-based anionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -X where R 1 is an alkyl, alkenyl or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR12## or COO; n is an integer of 8-30; X is SO 3 Na, COONa, OSO 3 Na or ONa; and (b) a surfactant of a second group which is a polyoxyethylene-based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR13## or COO; n is an integer of 8-30.

Claim 4

Dependent Claim 175 words

A reagent for classifying leukocytes in a blood sample that lyses erythrocytes and which acts on leukocytes to enable the classification and counting of leukocytes, said reagent consisting essentially of a solubilizing agent that selectively reduces the size of monocytes in leukocytes and at least one surfactant selected from the group consisting of: (a) a surfactant of a first group which is a polyoxyethylene-based anionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -X where R 1 is an alkyl, alkenyl or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR12## or COO; n is an integer of 8-30; X is SO 3 Na, COONa, OSO 3 Na or ONa; and (b) a surfactant of a second group which is a polyoxyethylene-based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 10-22 carbon atoms; R 2 is --O--, ##STR13## or COO; n is an integer of 8-30.

Claim 5

Dependent Claim 16 words

The reagent set forth in claim 1 which also contains a surfactant in the first fluid.

Claim 6

Dependent Claim 26 words

A method of detecting abnormal cells by the Radio Frequency and Direct Current particle analyzing methods using a reagent set forth in claim 1 or 2.

Claim 7

Dependent Claim 36 words

A method of classifying leukocytes into three types, lymphocytes, monocytes and granulocytes, and detecting abnormal cells by the Radio Frequency and Direct Current particle analyzing methods using a reagent set forth in claim 1 or 2.

Claim 8

Dependent Claim 63 words

A reagent for classifying leukocytes which is composed of the following two fluids (a) and (b): (a) a first fluid which is a blood diluent and which contains a hyperosmotic agent; and (b) a second fluid that contains the reagent set forth in claim 2 and which is to be added to a blood sample that has been diluted with the first fluid.

Claim 9

Dependent Claim 14 words

The reagent of claim 6 which also contains a surfactant in the first fluid.

Claim 10

Dependent Claim 11 words

The reagent of claim 2 which also contains a hyperosmotic agent.

Claim 11

Independent Claim 67 words

A method of classifying leukocytes into lymphocytes, monocytes, and granulocytes by (a) detecting the change in electrical impedance at high frequency (Radio Frequency method) or by (b) detecting the change in current due to the differences in conductivity between suspended particles and a fluid medium in which they are suspended (Direct Current method) using the reagent as in any one of claims 2, 6, 7 or 8.

Claim 12

Dependent Claim 58 words

A method of classifying leukocytes into lymphocytes,.monocytes, and granulocytes by (1) detecting the change in electrical impedance at high frequency (Radio Frequency method) or by (2) detecting the change in current due to the differences in conductivity between suspended particles and a fluid medium in which they are suspended (Direct Current method) using the reagent of claim 1.

Claim 13

Dependent Claim 86 words

A method of classifying leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, which comprises (a) classifying the leukocytes in a blood sample into three types, lymphocytes, monocytes and granulocytes, by the method set forth in claim 9, and (b) counting by both the Radio Frequency and Direct Current methods or by the Direct Current method alone eosinophils that selectively remain intact after the passage of a predetermined period of time in the sample that has been used for classification into three types.

Claim 14

Dependent Claim 78 words

A method of classifying leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, which comprises (a) classifying the leukocytes in a blood sample into three types, lymphocytes, monocytes and granulocytes, by the method set forth in claim 9, and (b) counting by both the Radio Frequency and Direct Current methods or by the Direct Current method alone eosinophils that are selectively left intact in another portion of the same blood sample by using a reagent.

Claim 15

Dependent Claim 81 words

A method of classifying leukocytes into five types, lymphocytes, monocytes, eosinophils, basophils and neutrophils, which comprises (a) classifying the leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, by the method set forth in claim 11 and (b) counting by both the Radio Frequency and Direct Current methods or by the Direct Current method alone basophils that are selectively left intact in another portion of the same blood sample by using a reagent for the measurement of basophils.

Claim 16

Dependent Claim 113 words

A reagent for enabling leukocytes in a blood sample to be classified and measured by lysing erythrocytes and protecting leukocyte membranes consisting essentially of a first cytolytic solution, having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the general formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; R 2 is --O--, ##STR14## or --COO--; and n is an integer of 20-100.

Claim 17

Dependent Claim 113 words

A reagent for enabling leukocytes in a blood sample to be classified and measured by lysing erythrocytes and protecting leukocyte membranes consisting essentially of a first cytolytic solution, having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the general formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; R 2 is --O--, ##STR14## or --COO--; and n is an integer of 20-100.

Claim 18

Dependent Claim 33 words

A reagent as recited in claim 14, further consisting essentially of a second cytolytic solution combined with the first cytolytic solution, said reagent having a pH of 5.0-12.0, an osmolarity of 150-2000 mOsm/kg.

Claim 19

Dependent Claim 74 words

The reagent according to claim 15 wherein the second solution contains an additional amount of said polyoxyethylene based nonionic surfactant effective to further improve separation of lymphocytes, monocytes and granulocytes represented by the general formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; R 2 is --O--, ##STR15## or --COO--; and n is an integer of 20-100.

Claim 20

Dependent Claim 86 words

A method of classifying leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, which comprises: (a) classifying the leukocytes in a blood sample into three types, lymphocytes, monocytes and granulocytes, by the method set forth in claim 10, and (b) counting by both the Radio Frequency and Direct Current methods or by the Direct Current method alone eosinophils that selectively remain intact after the passage of a predetermined period of time in the sample that has been used for classification into three types.

Claim 21

Dependent Claim 77 words

A method of classifying leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, which comprises: (a) classifying the leukocytes in a blood sample into three types, lymphocytes, monocytes and granulocytes, by the method set forth in claim 10, and (b) counting by the Radio Frequency and Direct Current methods or by the Direct Current method alone eosinophils that are selectively left intact in another portion of the same blood sample by using a reagent.

Claim 22

Dependent Claim 81 words

A method of classifying leukocytes into five types, lymphocytes, monocytes, eosinophils, basophils and neutrophils, which comprises: (a) classifying the leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, by the method set forth in claim 12 and (b) counting by both the Radio Frequency and Direct current methods or by the Direct Current method alone basophils that are selectively left intact in another portion of the same blood sample by using a reagent for the measurement of basophils.

Claim 23

Dependent Claim 81 words

A method of classifying leukocytes into five types, lymphocytes, monocytes, eosinophils, basophils and neutrophils, which comprises: (a) classifying the leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, by the method set forth in claim 17, and (b) counting by both the Radio Frequency and Direct current methods or by the Direct Current method alone basophils that are selectively left intact in another portion of the same blood sample by using a reagent for the measurement of basophils.

Claim 24

Dependent Claim 81 words

A method of classifying leukocytes into five types, lymphocytes, monocytes, eosinophils, basophils and neutrophils, which comprises: (a) classifying the leukocytes into four types, lymphocytes, monocytes, eosinophils and granulocytes other than eosinophils, by the method set forth in claim 18, and (b) counting by both the Radio Frequency and Direct current methods or by the Direct Current method alone basophils that are selectively left intact in another portion of the same blood sample by using a reagent for the measurement of basophils.

Claim 25

Dependent Claim 105 words

The reagent according to claim 15 wherein the second cytolytic solution contains at least one additive for improving the separation of leukocytes during classification and measurement, said at least one additive being selected from the group consisting of: urea thiourea 1, 1-dimethylurea ethyleneurea methylurethane 1, 3-dimethylurea urethane (H 2 NCOOC 2 H 5 ) N-octyl B-D-glucoside CHAPS (3-{(3-chloroamidopropy)dimethylammonio}-1-propanesullfonate) CHAPSO (3-{(3-chloroamidopropyl) dimethyl-ammonio}-2-hydroxy-1-propanesulfonate) MEGA 8,9,10 (octanoyl-, nonanoyl- or decanoyl-N-methylglucamide) sucrose monocaprate N-formylmethylleucylalanine guanidine thiocyanate guanylguanidine guanidine chloride guanidine rhodanate guanidine nitrate 1,1,3,3-tetraguanidine guanidine carbonate guanidine phosphate guanidine sulfate sodium deoxycholate taurocholic acid cholic acid sodium trichloroacetate sodium tribromoacetate sodium dichloroacetate sodium dibromoacetate sodium monochloroacetate and sodium monobromoacetate.

Claim 26

Dependent Claim 92 words

The reagent set forth in claim 1 or 2 wherein the contained solubilizing agent is at least one member selected from the group consisting of: urea thiourea 1, 1-dimethylurea ethyleneurea methylurethane 1, 3-dimethylurea urethane (H 2 NCOOC 2 H 5 ) N-octyl B-D-glucoside CHAPS (3-{(3-chloroamidopropy)dimethylammonio}-1-propanesullfonate) CHAPSO (3-{(3-chloroamidopropyl) dimethylammonio}-2-hydroxy-1-propanesulfonate) MEGA 8,9,10 (octanoyl-, nonanoyl- or decanoyl-N-methylglucamide) sucrose monocaprate N-formylmethylleucylalanine guanidine thiocyanate guanylguanidine guanidine chloride guanidine rhodanate guanidine nitrate 1,1,3,3-tetraguanidine guanidine carbonate guanidine phosphate guanidine sulfate sodium deoxycholate taurocholic acid cholic acid sodium trichloroacetate sodium tribromoacetate sodium dichloroacetate sodium dibromoacetate sodium monochloroacetate, and sodium monobromoacetate.

Claim 27

Dependent Claim 39 words

A method of classifying leukocytes according to claim 1 or 2 using a reagent that contains at least one of the solubilizing agents: n-octyl-B-D-glucoside CHAPS (3-{(3-chloramidopropyl)dimethylammonio}-1-propanesulfonate) CHAPSO (3-{3-chloramidopropyl-dimethyl-ammonio}-2-hydroxy-1-propanesulfonate) MEGA 8, 9, 10 (octanoyl-, nonanoyl- or decanoyl-N-methylglucamide) sucrose monocaprate N-formylmethylleucylalanine.

Claim 28

Independent Claim 150 words

A method for classifying leukocytes into at least three types, including lymphocytes, monocytes and granulocytes, comprising the steps of: (a) treating a blood sample with a reagent capable of lysing erythrocytes and protecting leukocyte membranes for subsequent classification, said reagent having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg, and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; R 2 is --O--, ##STR16## or --COO--; and n is an integer in the range 20-100; (b) measuring the DC volume and RF size to produce a scattergram; and (c) observing populations of the at least three types of leukocytes.

Claim 29

Independent Claim 150 words

A method for classifying leukocytes into at least three types, including lymphocytes, monocytes and granulocytes, comprising the steps of: (a) treating a blood sample with a reagent capable of lysing erythrocytes and protecting leukocyte membranes for subsequent classification, said reagent having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg, and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; R 2 is --O--, ##STR16## or --COO--; and n is an integer in the range 20-100; (b) measuring the DC volume and RF size to produce a scattergram; and (c) observing populations of the at least three types of leukocytes.

Claim 30

Independent Claim 141 words

A method for detecting abnormal leukocytes and nucleate erythrocytes, comprising the steps of: (a) treating a blood sample with a reagent capable of lysing erythrocytes and protecting leukocyte membranes for subsequent classification, said reagent having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg, and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; 2 is --O--, ##STR17## or --COO--; and n is an integer in the range 20-100; (b) measuring the DC volume and RF size to produce a scattergram; and (c) observing populations of abnormal leukocytes and nucleate erythrocytes.

Claim 31

Independent Claim 141 words

A method for detecting abnormal leukocytes and nucleate erythrocytes, comprising the steps of: (a) treating a blood sample with a reagent capable of lysing erythrocytes and protecting leukocyte membranes for subsequent classification, said reagent having a pH of 1.5-5.0, an osmolarity of 10-120 mOsm/kg, and containing a surfactant in an amount effective to reduce erythrocyte ghosts for distinction from leukocytes without causing undesirable leukocyte damage, said surfactant consisting essentially of a polyoxyethylene based nonionic surfactant represented by the formula: R 1 -R 2 -(CH 2 CH 2 O) n -H where R 1 is an alkyl, alkenyl or alkynyl group having 12-22 carbon atoms; 2 is --O--, ##STR17## or --COO--; and n is an integer in the range 20-100; (b) measuring the DC volume and RF size to produce a scattergram; and (c) observing populations of abnormal leukocytes and nucleate erythrocytes.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	1998-02-13	1998-08-15	1999-02-14	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2002-02-13	2002-08-15	2003-02-14	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2006-02-13	2006-08-15	2007-02-14	$7700.00	Window Closed / Lapsed

Method for classifying leukocytes and a reagent used therefor

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag